SCHEMBL30953361

SCHEMBL30953361

CC1CCC([C@H](N)C(=O)Nc2cc(C(NC(=O)CCC(F)(F)F)C3CC3)ccn2)CC1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.35
▸ LMNA P02545 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ NR3C2 P08235 2/20 0.35
▸ USP30 Q70CQ3 1/20 0.34
▸ ALOX12 P18054 1/20 0.33
▸ LNPEP Q9UIQ6 2/20 0.32
▸ GSK3B P49841 3/20 0.32
▸ DYRK1A Q13627 1/20 0.32
▸ PDE2A O00408 1/20 0.31
▸ TRPV1 Q8NER1 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ CBLB Q13191 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30953425 0.89 NR3C2 (0.34) RAB9ANPC1MEN1TP53TSHR
SCHEMBL30953477 0.89 NR3C2 (0.34) RAB9ANPC1MEN1TP53TSHR
SCHEMBL30953245 0.88 NR3C2 (0.36) RAB9ANPC1MEN1TP53TSHR
SCHEMBL30953240 0.87 MAPK1 (0.34) RAB9ALMNANPC1MEN1TP53
SCHEMBL30953063 0.85 AAK1 (0.42) RAB9ALMNANPC1MEN1TP53
SCHEMBL30953539 0.81 IGF1R (0.36) RAB9ANPC1MEN1TP53TSHR
SCHEMBL30953241 0.81 ACACB (0.36) NR3C2LNPEPGSK3BTRPV1MAPT
SCHEMBL30953277 0.81 ACACB (0.36) RAB9ANPC1MEN1TP53TSHR
SCHEMBL30953482 0.81 ACACB (0.36) RAB9ANPC1MEN1TP53TSHR
SCHEMBL30953420 0.79 SMYD3 (0.38) RAB9ANPC1ALOX12PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback